Endovascular Management of Type Ib Endoleak Complicating a Juxtarenal Aortic Aneurysm Previously Treated with a Multilayer Stent

Systematic Review and Patient-Level Meta-analysis of the Streamliner Multilayer Flow Modulator in the Management of Complex Thoracoabdominal Aortic Pathology

“…Changes in aneurysm diameter (Table 5) were reported at varying time points. Three case reports cited decreases in diameter: 0.5 cm at 18 months, 4 2.4 cm at 3 months, 5 and 0.5 cm at 12 months. 12…”

“…Eligible studies included 2 prospective studies 6,18 (1 prospective multicenter nonrandomized trial 18 ), 4 observational studies, 10,14–16 and 9 case reports. 4,5,7–9,11–13,17 Quality assessment of the 6 case series using the MINORS scale returned a mean of 9.8 out of a maximum of 16 (Table 3). Using the NOS (Table 4), all 6 studies rated 3 out of 4 stars for cohort selection but received low scores (1 star) in other applicable items, with the exception of 2 prospective studies 6,18 that rated 3 out of 3 stars for outcome.…”

“…Seven studies provided information on postoperative antiplatelet therapy. Patients were treated with either dual antiplatelet therapy consisting of clopidogrel (75 mg/d) plus aspirin (100 mg/d) 4,7,12,13,17,18 or clopidogrel only. 9…”

“…One patient was readmitted 12 months post SMFM because of Failure Mode I and was treated with a bifurcated stent-graft; CTA at 18 months showed visceral artery patency, no endoleak, and sac shrinkage. 4…”

“…Of the 121 articles identified, 55 abstracts were considered relevant, and full articles were obtained and assessed. Fifteen articles met the criteria for inclusion 4–18 (Figure 1 and Table 1).…”